Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Elizabeth McFarland

Concepts (388)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
52
2026
3082
3.200
 Why?
HIV-1
28
2026
907
2.900
 Why?
Respiratory Syncytial Virus Vaccines
6
2022
39
2.230
 Why?
HIV Antibodies
14
2026
67
2.220
 Why?
Respiratory Syncytial Virus Infections
6
2022
136
2.040
 Why?
Respiratory Syncytial Virus, Human
6
2022
82
2.020
 Why?
Infectious Disease Transmission, Vertical
18
2025
186
2.010
 Why?
Anti-HIV Agents
15
2026
869
1.770
 Why?
Anti-Retroviral Agents
12
2023
241
1.650
 Why?
Viral Proteins
3
2020
366
1.480
 Why?
Antibodies, Neutralizing
10
2026
347
1.110
 Why?
Antibodies, Viral
8
2022
686
1.060
 Why?
Antibodies, Monoclonal
7
2026
1524
0.950
 Why?
Colonography, Computed Tomographic
3
2024
8
0.920
 Why?
Pregnancy Complications, Infectious
9
2026
424
0.890
 Why?
HIV Protease Inhibitors
3
2026
69
0.830
 Why?
AIDS Vaccines
8
2018
54
0.820
 Why?
Pre-Exposure Prophylaxis
1
2025
243
0.760
 Why?
Gene Deletion
2
2020
388
0.700
 Why?
Breast Feeding
4
2025
449
0.620
 Why?
Atazanavir Sulfate
2
2017
42
0.610
 Why?
Ritonavir
2
2017
74
0.590
 Why?
Infant, Newborn
24
2026
6406
0.560
 Why?
Vaccination
6
2020
1423
0.550
 Why?
HIV Envelope Protein gp120
6
2017
61
0.550
 Why?
Vaccines, Attenuated
6
2022
130
0.550
 Why?
Incidental Findings
1
2018
81
0.520
 Why?
Infant
33
2026
9987
0.520
 Why?
Radiation Dosage
1
2018
190
0.490
 Why?
Nelfinavir
1
2016
8
0.490
 Why?
Telemedicine
1
2025
952
0.480
 Why?
Lopinavir
1
2016
30
0.480
 Why?
Syncope
1
2016
55
0.480
 Why?
Bradycardia
1
2016
57
0.470
 Why?
Patient Dropouts
1
2016
65
0.470
 Why?
Lyme Disease
1
2016
58
0.460
 Why?
Health Resources
1
2016
131
0.440
 Why?
Infant, Newborn, Diseases
1
2016
114
0.430
 Why?
HIV
5
2014
248
0.400
 Why?
Humans
78
2026
144859
0.380
 Why?
Patient Compliance
2
2018
614
0.370
 Why?
Child
38
2026
22620
0.370
 Why?
Female
52
2026
78217
0.370
 Why?
Immunogenicity, Vaccine
4
2021
36
0.370
 Why?
Referral and Consultation
1
2018
847
0.350
 Why?
T-Lymphocytes, Cytotoxic
4
2005
179
0.340
 Why?
Male
43
2026
72189
0.340
 Why?
CD4-Positive T-Lymphocytes
2
2017
1147
0.330
 Why?
Virus Replication
4
2020
538
0.330
 Why?
Adolescent
28
2025
22396
0.330
 Why?
Viral Load
10
2026
517
0.310
 Why?
Lymphocyte Activation
5
2017
1143
0.300
 Why?
Young Adult
14
2026
14033
0.280
 Why?
HIV Seropositivity
2
2023
119
0.270
 Why?
DNA, Viral
3
2026
361
0.260
 Why?
Bone Density
2
2025
501
0.260
 Why?
Double-Blind Method
3
2020
2030
0.250
 Why?
RNA, Viral
8
2023
693
0.240
 Why?
Antibodies, Bacterial
2
2018
147
0.230
 Why?
Dyslipidemias
2
2017
171
0.230
 Why?
Antiretroviral Therapy, Highly Active
6
2017
278
0.220
 Why?
Bone Development
1
2025
56
0.220
 Why?
Prenatal Exposure Delayed Effects
2
2026
678
0.220
 Why?
Immunoenzyme Techniques
1
2005
201
0.220
 Why?
Puberty
1
2026
154
0.210
 Why?
Pregnancy
12
2026
7197
0.210
 Why?
Immunoglobulin G
3
2022
899
0.210
 Why?
Diverticulum
1
2024
15
0.210
 Why?
Viremia
3
2011
158
0.210
 Why?
Gene Products, gag
2
1994
38
0.200
 Why?
Mammography
1
2025
165
0.200
 Why?
Child, Preschool
21
2022
11740
0.190
 Why?
Squalene
3
2017
8
0.190
 Why?
Complementarity Determining Regions
1
2002
53
0.190
 Why?
Prospective Studies
5
2025
7947
0.180
 Why?
Drug Resistance, Viral
2
2016
119
0.180
 Why?
CD4 Lymphocyte Count
4
2017
276
0.180
 Why?
Half-Life
1
2021
150
0.170
 Why?
Growth Differentiation Factor 15
1
2021
41
0.170
 Why?
Feasibility Studies
1
2025
1086
0.170
 Why?
Immunization Schedule
2
2018
187
0.170
 Why?
Mitochondrial Diseases
1
2021
92
0.170
 Why?
Colorado
4
2025
4606
0.170
 Why?
Drug Therapy, Combination
4
2017
1033
0.160
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
335
0.160
 Why?
RNA, Small Untranslated
1
2020
14
0.160
 Why?
Fibroblast Growth Factors
1
2021
188
0.160
 Why?
T-Lymphocytes
2
2009
2045
0.160
 Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.160
 Why?
Pilot Projects
1
2025
1873
0.150
 Why?
Hydrophobic and Hydrophilic Interactions
1
2020
192
0.150
 Why?
Cytokines
2
2021
2100
0.150
 Why?
Point Mutation
1
2020
245
0.140
 Why?
Body Temperature
1
2020
224
0.140
 Why?
Immunocompromised Host
2
2000
202
0.140
 Why?
Haemophilus Vaccines
2
2018
29
0.140
 Why?
Insulin Resistance
3
2019
1255
0.140
 Why?
Immunologic Memory
2
2021
376
0.140
 Why?
Darunavir
1
2017
20
0.130
 Why?
Interleukin-12
1
1998
121
0.130
 Why?
Metabolic Syndrome
1
2021
366
0.130
 Why?
CD8-Positive T-Lymphocytes
2
2011
949
0.130
 Why?
Mycobacterium Infections, Nontuberculous
2
2012
367
0.130
 Why?
Dose-Response Relationship, Drug
1
2021
2037
0.130
 Why?
Therapeutic Equipoise
1
2017
2
0.130
 Why?
Interferon-gamma
5
2012
792
0.130
 Why?
Antibody Formation
1
2018
294
0.130
 Why?
Lymphopoiesis
1
2017
27
0.130
 Why?
Immunoglobulin A
2
2017
218
0.130
 Why?
Uganda
1
2017
93
0.130
 Why?
Receptors, CCR5
1
2017
61
0.130
 Why?
CD4-CD8 Ratio
1
2016
24
0.120
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.120
 Why?
High-Throughput Screening Assays
1
2018
174
0.120
 Why?
Adoption
1
2016
25
0.120
 Why?
Adult
16
2026
40438
0.120
 Why?
Mothers
3
2017
774
0.120
 Why?
Virus Latency
1
2016
90
0.120
 Why?
Cohort Studies
8
2025
5898
0.120
 Why?
Continuity of Patient Care
1
2018
287
0.110
 Why?
Early Diagnosis
1
2016
247
0.110
 Why?
Chickenpox Vaccine
1
2015
75
0.110
 Why?
Zimbabwe
2
2025
74
0.110
 Why?
Disease Susceptibility
1
2017
352
0.110
 Why?
Gene Products, env
1
1994
7
0.110
 Why?
Body Height
2
2017
202
0.110
 Why?
Chickenpox
1
2015
81
0.110
 Why?
Haemophilus influenzae type b
1
2014
12
0.110
 Why?
Bacterial Capsules
1
2014
33
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Acquired Immunodeficiency Syndrome
2
2000
230
0.110
 Why?
Cote d'Ivoire
2
2025
8
0.110
 Why?
Parotitis
1
2014
6
0.110
 Why?
South Africa
2
2025
221
0.100
 Why?
Vaccines, Synthetic
4
2005
140
0.100
 Why?
Developing Countries
1
2016
315
0.100
 Why?
Cytotoxicity, Immunologic
3
2002
227
0.100
 Why?
Puberty, Delayed
1
2013
10
0.100
 Why?
Intestines
1
2017
358
0.100
 Why?
Leukocytes, Mononuclear
4
2013
580
0.100
 Why?
Vaccines
1
2018
389
0.100
 Why?
RNA-Directed DNA Polymerase
1
1993
35
0.100
 Why?
Mycobacterium chelonae
1
1993
9
0.100
 Why?
Injections, Subcutaneous
2
2026
166
0.100
 Why?
Patient Selection
1
2017
699
0.090
 Why?
Lipids
1
2017
701
0.090
 Why?
Lamivudine
3
2023
64
0.090
 Why?
Retrospective Studies
8
2023
16937
0.090
 Why?
Colorectal Neoplasms
1
2020
851
0.090
 Why?
Cell Movement
1
2017
977
0.090
 Why?
Cardiovascular Diseases
2
2016
2109
0.090
 Why?
Mitochondria
2
2021
988
0.090
 Why?
STAT1 Transcription Factor
1
2012
69
0.090
 Why?
Child Development
1
2017
495
0.090
 Why?
Pediatric Obesity
1
2019
633
0.090
 Why?
Body Fat Distribution
1
2011
46
0.090
 Why?
Clinical Trials as Topic
1
2017
1054
0.090
 Why?
Breast Neoplasms
1
2025
2517
0.090
 Why?
Body Weight
2
2017
993
0.090
 Why?
Polysorbates
3
2017
42
0.090
 Why?
Mycobacterium avium Complex
1
2012
89
0.090
 Why?
Epitopes
2
2022
491
0.080
 Why?
Cost-Benefit Analysis
2
2025
621
0.080
 Why?
Research Design
1
2017
1128
0.080
 Why?
United States
9
2023
15723
0.080
 Why?
Biomedical Research
1
2017
716
0.080
 Why?
Interleukin-2
2
2003
447
0.080
 Why?
Respiratory Tract Infections
1
2014
397
0.080
 Why?
Freezing
1
2009
86
0.070
 Why?
Exercise
1
2021
2206
0.070
 Why?
Absorptiometry, Photon
2
2025
277
0.070
 Why?
Blood
1
2009
112
0.070
 Why?
Phenotype
1
2017
3199
0.070
 Why?
Algorithms
1
2016
1848
0.070
 Why?
Age Factors
4
2019
3311
0.070
 Why?
Staff Development
1
2009
61
0.070
 Why?
T-Lymphocyte Subsets
2
2002
422
0.070
 Why?
Lymphocyte Subsets
2
2009
87
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2021
858
0.070
 Why?
Biomarkers
4
2021
4279
0.070
 Why?
Longitudinal Studies
3
2025
2971
0.070
 Why?
Enterovirus A, Human
1
2007
13
0.070
 Why?
Faculty
1
2009
151
0.070
 Why?
Specimen Handling
1
2009
188
0.070
 Why?
Withholding Treatment
1
2008
79
0.070
 Why?
Adipose Tissue
1
2011
657
0.060
 Why?
Central Nervous System Viral Diseases
1
2007
78
0.060
 Why?
Polymerase Chain Reaction
4
2011
1058
0.060
 Why?
Flow Cytometry
3
2009
1193
0.060
 Why?
Academic Medical Centers
1
2009
542
0.060
 Why?
Monte Carlo Method
1
2026
155
0.060
 Why?
False Negative Reactions
1
2025
63
0.060
 Why?
Enterovirus Infections
1
2007
174
0.050
 Why?
Isoantigens
1
1984
17
0.050
 Why?
C-Reactive Protein
2
2021
419
0.050
 Why?
Cell Line
3
2012
2911
0.050
 Why?
Medical Audit
1
2025
76
0.050
 Why?
Immunity, Cellular
1
2006
273
0.050
 Why?
Linear Models
2
2020
860
0.050
 Why?
Disease Outbreaks
1
2007
423
0.050
 Why?
Follow-Up Studies
3
2021
5350
0.050
 Why?
Confusion
1
2024
30
0.050
 Why?
Comorbidity
2
2021
1640
0.050
 Why?
Sequence Analysis, DNA
2
2007
829
0.050
 Why?
Thymus Gland
1
1984
317
0.050
 Why?
Tablets
1
2023
40
0.050
 Why?
Constriction, Pathologic
1
2024
248
0.050
 Why?
Regression Analysis
2
2021
1003
0.050
 Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
 Why?
Risk Factors
4
2021
10672
0.050
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.050
 Why?
Immunophenotyping
2
1994
327
0.050
 Why?
Zidovudine
2
2015
77
0.050
 Why?
Clone Cells
1
2002
269
0.040
 Why?
Dose-Response Relationship, Immunologic
1
2001
77
0.040
 Why?
Cough
1
2022
135
0.040
 Why?
Emtricitabine
1
2023
205
0.040
 Why?
Triazoles
1
2023
185
0.040
 Why?
Vaccines, Subunit
1
2001
53
0.040
 Why?
Pyridones
1
2023
200
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2021
52
0.040
 Why?
Ganciclovir
1
2000
53
0.040
 Why?
Tenofovir
1
2023
294
0.040
 Why?
Public Health Surveillance
1
2021
83
0.040
 Why?
Lung
1
2014
4190
0.040
 Why?
Africa
1
2020
113
0.040
 Why?
Computer Simulation
1
2005
1035
0.040
 Why?
Adjuvants, Immunologic
2
2017
246
0.040
 Why?
Diagnostic Tests, Routine
1
2021
110
0.040
 Why?
Sex Factors
2
2019
2090
0.040
 Why?
Symptom Assessment
1
2021
135
0.040
 Why?
HIV Seronegativity
1
2019
30
0.040
 Why?
Cross-Sectional Studies
3
2021
5809
0.040
 Why?
HLA-D Antigens
1
1999
30
0.040
 Why?
Risk
1
2021
905
0.040
 Why?
Case-Control Studies
2
2019
3628
0.040
 Why?
Cytomegalovirus Infections
1
2000
207
0.040
 Why?
Cholesterol, HDL
1
2019
195
0.040
 Why?
Lymphocyte Culture Test, Mixed
1
1998
51
0.040
 Why?
Cytotoxicity Tests, Immunologic
1
1998
37
0.040
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
27
0.040
 Why?
Prevalence
2
2016
2830
0.040
 Why?
Vaccines, Combined
1
2018
49
0.040
 Why?
Hospitals
1
2023
699
0.040
 Why?
Poliovirus Vaccine, Inactivated
1
2018
27
0.030
 Why?
Amino Acid Sequence
1
2002
2149
0.030
 Why?
Odds Ratio
1
2021
1058
0.030
 Why?
Hepatitis B Vaccines
1
2018
42
0.030
 Why?
Drug Resistance, Microbial
2
2000
70
0.030
 Why?
Mutation
3
2018
4132
0.030
 Why?
Molecular Sequence Data
1
2002
2914
0.030
 Why?
Colon
1
2020
305
0.030
 Why?
Nutrition Surveys
1
2019
279
0.030
 Why?
Case Management
1
2018
65
0.030
 Why?
Antigens, Viral
1
1998
183
0.030
 Why?
Cholesterol, LDL
1
2019
349
0.030
 Why?
Cholesterol
1
2019
398
0.030
 Why?
Epitopes, T-Lymphocyte
1
1998
186
0.030
 Why?
Triglycerides
1
2019
517
0.030
 Why?
Treatment Adherence and Compliance
1
2017
28
0.030
 Why?
Immune Tolerance
1
1999
384
0.030
 Why?
Disease Management
1
2021
639
0.030
 Why?
Reproducibility of Results
1
2005
3411
0.030
 Why?
Lymphocyte Count
2
2009
169
0.030
 Why?
Cell Division
1
1998
780
0.030
 Why?
Uncertainty
1
2017
144
0.030
 Why?
Treatment Failure
1
2017
364
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Multicenter Studies as Topic
1
2017
399
0.030
 Why?
Seroepidemiologic Studies
1
2015
174
0.030
 Why?
Patient Outcome Assessment
1
2016
133
0.030
 Why?
Genes, pol
1
1994
7
0.030
 Why?
Malnutrition
1
2016
86
0.030
 Why?
Antiviral Agents
1
2000
749
0.030
 Why?
Maternal Exposure
1
2017
215
0.030
 Why?
Time-to-Treatment
1
2017
237
0.030
 Why?
Vaccines, Conjugate
1
2014
60
0.030
 Why?
Coinfection
1
2016
141
0.030
 Why?
Counseling
1
2018
402
0.030
 Why?
Neutropenia
1
2015
156
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1701
0.030
 Why?
Treatment Outcome
2
2021
11581
0.030
 Why?
Cells, Cultured
2
2008
4177
0.030
 Why?
Global Health
1
2017
395
0.030
 Why?
Anemia
1
2015
180
0.030
 Why?
Sexual and Gender Minorities
1
2018
250
0.020
 Why?
Maternal-Fetal Exchange
1
2014
169
0.020
 Why?
Electron Transport Complex IV
1
2013
62
0.020
 Why?
Electron Transport Complex I
1
2013
42
0.020
 Why?
Thrombocytopenia
1
2015
208
0.020
 Why?
Tuberculosis, Cutaneous
1
1993
2
0.020
 Why?
HIV Reverse Transcriptase
1
1993
31
0.020
 Why?
CD8 Antigens
1
1993
74
0.020
 Why?
Medication Adherence
1
2017
523
0.020
 Why?
Radiography, Thoracic
1
2014
176
0.020
 Why?
Severity of Illness Index
1
2021
2940
0.020
 Why?
CD3 Complex
1
1993
112
0.020
 Why?
Drug Administration Schedule
2
2008
779
0.020
 Why?
Blood Pressure
1
2019
1752
0.020
 Why?
Oxidative Phosphorylation
1
2013
211
0.020
 Why?
Lymphocytes
1
1994
396
0.020
 Why?
DNA, Mitochondrial
1
2013
206
0.020
 Why?
P-Selectin
1
2011
28
0.020
 Why?
E-Selectin
1
2011
61
0.020
 Why?
Heteroduplex Analysis
1
2011
1
0.020
 Why?
Tuberculosis, Pulmonary
1
1993
131
0.020
 Why?
Pandemics
1
2020
1685
0.020
 Why?
Chemokine CCL2
1
2011
115
0.020
 Why?
Antigens, CD
1
1994
564
0.020
 Why?
Blood Transfusion
1
1994
405
0.020
 Why?
Hyperlipidemias
1
2011
121
0.020
 Why?
Interferon-alpha
1
2012
184
0.020
 Why?
Cell Proliferation
2
2009
2543
0.020
 Why?
Protein Multimerization
1
2012
209
0.020
 Why?
Fibrinogen
1
2011
180
0.020
 Why?
Nontuberculous Mycobacteria
1
1993
210
0.020
 Why?
Cell Adhesion Molecules
1
2011
178
0.020
 Why?
Hospitalization
1
2021
2359
0.020
 Why?
Cross Infection
1
1993
262
0.020
 Why?
Healthcare Disparities
1
2017
712
0.020
 Why?
Infant, Premature
1
1994
612
0.020
 Why?
Diagnosis, Differential
1
2014
1504
0.020
 Why?
Pokeweed Mitogens
1
2009
7
0.020
 Why?
L-Selectin
1
2009
27
0.020
 Why?
Human Experimentation
1
2009
13
0.020
 Why?
Tetanus
1
2009
26
0.020
 Why?
Leukocyte Common Antigens
1
2009
87
0.020
 Why?
Candida
1
2009
44
0.020
 Why?
Multivariate Analysis
1
2011
1510
0.020
 Why?
Obesity
1
2021
3107
0.020
 Why?
Meningitis, Aseptic
1
2007
13
0.020
 Why?
Virus Cultivation
1
2007
31
0.020
 Why?
Phosphorylation
1
2012
1763
0.020
 Why?
Interleukin-6
1
2011
791
0.020
 Why?
Cerebrospinal Fluid
1
2007
92
0.020
 Why?
Data Interpretation, Statistical
1
2009
371
0.020
 Why?
Paralysis
1
2007
67
0.020
 Why?
Multiple Organ Failure
1
2007
125
0.020
 Why?
Pregnancy Outcome
1
2010
476
0.020
 Why?
B-Lymphocytes
1
2012
890
0.020
 Why?
Genotype
1
2011
1841
0.020
 Why?
Kinetics
1
2010
1627
0.020
 Why?
Respiratory System
1
2007
160
0.010
 Why?
Immunoglobulin A, Secretory
1
2005
8
0.010
 Why?
Cell Survival
1
2009
1113
0.010
 Why?
Phosphates
1
1987
179
0.010
 Why?
Muscles
1
1987
334
0.010
 Why?
Encephalitis
1
2007
139
0.010
 Why?
Mucous Membrane
1
2005
128
0.010
 Why?
Gastrointestinal Tract
1
2007
207
0.010
 Why?
Chemistry, Physical
1
1984
38
0.010
 Why?
Antigen-Antibody Reactions
1
1984
50
0.010
 Why?
Chemical Phenomena
1
1984
80
0.010
 Why?
DNA-Binding Proteins
1
2012
1495
0.010
 Why?
Myasthenia Gravis
1
1984
23
0.010
 Why?
Immunologic Deficiency Syndromes
1
1984
69
0.010
 Why?
Tissue Distribution
1
1984
328
0.010
 Why?
Saliva
1
2005
251
0.010
 Why?
Epithelium
1
1984
316
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2798
0.010
 Why?
Blood Glucose
1
2013
2335
0.010
 Why?
Aging
2
2003
1980
0.010
 Why?
Body Mass Index
1
2011
2448
0.010
 Why?
Infusions, Intravenous
1
2003
427
0.010
 Why?
Middle Aged
2
2020
35939
0.010
 Why?
Reference Values
1
2003
807
0.010
 Why?
Anti-Bacterial Agents
1
1993
1913
0.010
 Why?
Mice, Inbred BALB C
1
1984
1272
0.010
 Why?
Suspensions
1
2000
29
0.010
 Why?
Capsules
1
2000
43
0.010
 Why?
Urban Population
1
2003
493
0.010
 Why?
Drug Tolerance
1
2000
100
0.010
 Why?
Cytomegalovirus
1
2000
168
0.010
 Why?
Signal Transduction
1
2012
5277
0.010
 Why?
Administration, Oral
1
2000
844
0.010
 Why?
Immunization
1
2000
375
0.010
 Why?
Epithelial Cells
1
1984
1133
0.010
 Why?
Time Factors
1
2008
7107
0.010
 Why?
Recombinant Proteins
1
2000
1358
0.010
 Why?
Macrophages
1
1984
1532
0.010
 Why?
Tail
1
1987
29
0.000
 Why?
Phosphocreatine
1
1987
44
0.000
 Why?
Salamandridae
1
1987
33
0.000
 Why?
Mice
1
1984
18549
0.000
 Why?
Animals
2
1987
38331
0.000
 Why?
Adenosine Triphosphate
1
1987
499
0.000
 Why?
Aged
1
1984
25822
0.000
 Why?
Magnetic Resonance Spectroscopy
1
1987
626
0.000
 Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (388) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)